
PACS Group is rated Buy, leveraging a proven model of acquiring and ramping skilled nursing facilities for higher occupancy and acuity. Recent acquisitions in Florida, Texas, and Eduro add 8,400 beds, supporting a multi-year growth cycle as these facilities ramp up. PACS trades at a 14.8% GAAP FWD P/E discount to sector median, with strong cash generation, low net leverage (0.2x), and rising guidance.










